The Prognostic Significance of Coronary Artery Disease Interventions in Lung Transplant Candidates

Eran Yerushalmi1, Tal Abu1, David Hasdai2,3

  • 1Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Cardiology
|January 6, 2025
PubMed

Insights

Routine coronary intervention before lung transplantation (LT) did not significantly reduce major adverse cardiac events (MACE) in LT candidates. Interventions may even increase MACE risk, particularly early post-procedure, suggesting careful consideration is needed.

Area of Science:

  • Cardiology
  • Thoracic Surgery
  • Transplantation Medicine

Background:

  • Lung transplantation (LT) is critical for end-stage lung failure.
  • Coronary artery disease (CAD) is prevalent in lung disease patients, necessitating pre-LT coronary angiography.
  • CAD interventions aim to reduce post-LT cardiovascular events.

Purpose of the Study:

  • To evaluate the prognostic impact of CAD interventions in lung transplant candidates.
  • To assess pre- and post-LT outcomes related to coronary interventions.

Main Methods:

  • Retrospective analysis of 450 LT candidates undergoing cardiac catheterization (2014-2019).
  • Assessment for significant CAD and percutaneous coronary intervention.
  • Primary outcome: Major Adverse Cardiac Events (MACE) on the waiting list; Secondary outcome: MACE post-LT.

Main Results:

  • Higher MACE incidence in the intervention group (8.3%) vs. non-intervention (4.4%), p=0.007.
  • 28.6% of MACE in the intervention group occurred within one month post-intervention.
  • No significant difference in cardiovascular mortality or post-LT MACE rates between groups.

Conclusions:

  • Pre-LT routine coronary intervention does not consistently prevent MACE in LT candidates.
  • Intervention status did not significantly alter post-LT MACE rates.
Abstract